4AFG

Capitella teleta AChBP in complex with varenicline

4AFG の概要

• エントリーDOI: 10.2210/pdb4afg/pdb
• 関連するPDBエントリー: 4AFH
• 分子名称: CAPITELLA TELETA ACHBP, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (7 entities in total)
• 機能のキーワード: acetylcholine-binding protein, nicotinic receptor, ion channel
• 由来する生物種: CAPITELLA TELETA
• タンパク質・核酸の鎖数: 5
• 化学式量合計: 136143.80

構造登録者

Brams, M.,Ulens, C.,Spurny, R. (登録日: 2012-01-19, 公開日: 2012-05-30, 最終更新日: 2024-10-09)

主引用文献

Billen, B.,Spurny, R.,Brams, M.,Van Elk, R.,Valera-Kummer, S.,Yakel, J.L.,Voets, T.,Bertrand, D.,Smit, A.B.,Ulens, C.
Molecular Actions of Smoking Cessation Drugs at Alpha4Beta2 Nicotinic Receptors Defined in Crystal Structures of a Homologous Binding Protein.
Proc.Natl.Acad.Sci.USA, 109:9173-, 2012

PubMed Abstract: Partial agonists of the α4β2 nicotinic acetylcholine receptor (nAChR), such as varenicline, are therapeutically used in smoking cessation treatment. These drugs derive their therapeutic effect from fundamental molecular actions, which are to desensitize α4β2 nAChRs and induce channel opening with higher affinity, but lower efficacy than a full agonist at equal receptor occupancy. Here, we report X-ray crystal structures of a unique acetylcholine binding protein (AChBP) from the annelid Capitella teleta, Ct-AChBP, in complex with varenicline or lobeline, which are both partial agonists. These structures highlight the architecture for molecular recognition of these ligands, indicating the contact residues that potentially mediate their molecular actions in α4β2 nAChRs. We then used structure-guided mutagenesis and electrophysiological recordings to pinpoint crucial interactions of varenicline with residues on the complementary face of the binding site in α4β2 nAChRs. We observe that residues in loops D and E are molecular determinants of desensitization and channel opening with limited efficacy by the partial agonist varenicline. Together, this study analyzes molecular recognition of smoking cessation drugs by nAChRs in a structural context.

PubMed: 22619328
DOI: 10.1073/PNAS.1116397109

実験手法

X-RAY DIFFRACTION (2.001 Å)